Paper Title
Review On Drug Discovery And Development
Article Identifiers
: Authors
Keywords
Lead optimization, clinical trials, target validation, identification, Clinical Phases, Clinical Phase Trials, Preclinical Trials, Federal Drug Administration.
Abstract
Finding a therapeutically effective molecule for the treatment and cure of disease is the goal of drug discovery. The selection of candidates, synthesis, characterisation, validation, optimization, screening, and tests for therapeutic efficacy are all parts of this process. A molecule will start the medication development process prior to clinical trials once it has demonstrated its importance in these studies. A new drug must go through a number of stages of development in order to be produced that is both safe and efficient and meets all regulatory standards. One overarching theme of our article is that because the process is so drawn out, expensive, and complex, numerous biological targets must be taken into account before any new medication is finally approved for clinical use. Additionally, new research tools may be required to examine each new target. It takes time and effort to develop a drug that can be sold. From the time of discovery until the treatment is licenced, it takes roughly 12 to 15 years and costs about US $1 billion. A million molecules are typically tested, but only one is examined in advanced clinical trials and ultimately made available to patients. An overview of the procedures for discovering and developing novel drugs is given in this article.
Downloads
How To Cite (APA)
Tanuja Bhausaheb Kolhe, Gajanan Keshav Gajmal, Ayaz Ahmad Aadam Shah, Dhananjay Machindra Patil, & Deepak Devidas Sonawane (September-2022). Review On Drug Discovery And Development. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(9), 508-519. https://ijnrd.org/papers/IJNRD2209060.pdf
Issue
Volume 7 Issue 9, September-2022
Pages : 508-519
Other Publication Details
Paper Reg. ID: IJNRD_182893
Published Paper Id: IJNRD2209060
Downloads: 000122000
Research Area: Pharmacy
Author Type: Indian Author
Country: Nashik, Maharashtra, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2209060.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2209060
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: November 2025
Current Issue: Volume 10 | Issue 11 | November 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 30-Nov-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
